Assenagon Asset Management S.A. Rhythm Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 224,128 shares of RYTM stock, worth $24 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

224,128

Previous 237,998 5.83%

Holding current value

$24 Million

Previous $15 Million 50.5%

% of portfolio

0.03%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	SELL	$65.14 - $104.57 $903,491 - $1.45 Million	-13,870 Reduced 5.83%	224,128 $22.6 Million
Q2 2025 Jul 11, 2025	BUY	$46.95 - $68.11 $10.1 Million - $14.7 Million	215,806 Added 972.45%	237,998 $15 Million
Q1 2025 Apr 15, 2025	BUY	$48.56 - $61.02 $1.08 Million - $1.35 Million	22,192 New	22,192 $1.22 Million
Q3 2024 Oct 23, 2024	SELL	$40.81 - $55.0 $8.55 Million - $11.5 Million	-209,439 Reduced 91.26%	20,052 $1.05 Million
Q2 2024 Jul 18, 2024	SELL	$35.41 - $44.37 $1.99 Million - $2.49 Million	-56,160 Reduced 19.66%	229,491 $9.42 Million
Q1 2024 Apr 24, 2024	SELL	$39.12 - $52.44 $625,333 - $838,253	-15,985 Reduced 5.3%	285,651 $12.4 Million
Q4 2023 Jan 17, 2024	SELL	$21.39 - $49.64 $2.26 Million - $5.24 Million	-105,654 Reduced 25.94%	301,636 $13.9 Million
Q3 2023 Nov 06, 2023	SELL	$15.81 - $27.8 $2.15 Million - $3.78 Million	-135,920 Reduced 25.02%	407,290 $9.34 Million
Q2 2023 Jul 25, 2023	SELL	$16.32 - $21.15 $1.97 Million - $2.56 Million	-120,816 Reduced 18.19%	543,210 $8.96 Million
Q1 2023 Apr 18, 2023	BUY	$16.88 - $34.24 $3.38 Million - $6.87 Million	200,510 Added 43.26%	664,026 $11.8 Million
Q4 2022 Jan 12, 2023	SELL	$22.21 - $30.25 $153,115 - $208,543	-6,894 Reduced 1.47%	463,516 $13.5 Million
Q3 2022 Oct 27, 2022	SELL	$4.3 - $30.85 $943,033 - $6.77 Million	-219,310 Reduced 31.8%	470,410 $11.5 Million
Q2 2022 Jul 27, 2022	SELL	$3.12 - $12.25 $50,544 - $198,450	-16,200 Reduced 2.29%	689,720 $2.86 Million
Q1 2022 Apr 25, 2022	BUY	$6.13 - $12.24 $129,796 - $259,169	21,174 Added 3.09%	705,920 $8.13 Million
Q4 2021 Feb 01, 2022	BUY	$8.62 - $13.9 $1.57 Million - $2.54 Million	182,476 Added 36.33%	684,746 $6.83 Million
Q3 2021 Oct 19, 2021	BUY	$11.68 - $20.72 $4.2 Million - $7.46 Million	359,798 Added 252.54%	502,270 $6.56 Million
Q2 2021 Jul 15, 2021	BUY	$18.52 - $22.55 $2.64 Million - $3.21 Million	142,472 New	142,472 $2.79 Million

Others Institutions Holding RYTM

# of Institutions

252

Shares Held

64.3M

Call Options Held

210K

Put Options Held

575K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $5.97B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Rhythm Pharmaceuticals, Inc. Transaction History